Related Experiment Videos
Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders
The British Journal of Dermatology
|August 14, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dry or wet? Fluid therapy in upper gastrointestinal surgery patients.
Updates in surgery·2022
Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Frontiers in immunology·2020
Resistance of Transgenic Prunus domestica to Plum Pox Virus Infection.
Plant disease·2019
Healthcare Providers' Perspectives on Nonsegmental Vitiligo Severity, Patient Impact, and Treatment Gaps in the United States and Europe.
The British journal of dermatology·2026
Time-of-day-dependent immune dynamics are associated with disease severity and therapeutic response in psoriasis.
The British journal of dermatology·2026
Deciphering keloid formation and treatment: insights from mechanobiology.
The British journal of dermatology·2026
Up-regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy.
British journal of pharmacology·2026
Mistakes in the management of irritable bowel syndrome-diarrhoeal subtype and mimics: a narrative review.
Current medical research and opinion·2026
Kikuchi-Fujimoto Disease - A Case Report in a Middle-aged Adult.
Annals of African medicine·2026
The role of glucagon-like peptide 1 receptor agonists in the management of patients with inflammatory bowel diseases.
Inflammatory bowel diseases·2026
Association between body composition and perimenopausal symptom severity in Irish women.
Post reproductive health·2026